SK7342000A3 - Formulations comprising dissolved paroxetine - Google Patents

Formulations comprising dissolved paroxetine Download PDF

Info

Publication number
SK7342000A3
SK7342000A3 SK734-2000A SK7342000A SK7342000A3 SK 7342000 A3 SK7342000 A3 SK 7342000A3 SK 7342000 A SK7342000 A SK 7342000A SK 7342000 A3 SK7342000 A3 SK 7342000A3
Authority
SK
Slovakia
Prior art keywords
paroxetine
solid
capsules
carrier
capsule
Prior art date
Application number
SK734-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK7342000A3 publication Critical patent/SK7342000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK734-2000A 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine SK7342000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (fr) 1997-11-21 1998-11-18 Formulations contenant de la paroxetine dissoute

Publications (1)

Publication Number Publication Date
SK7342000A3 true SK7342000A3 (en) 2000-12-11

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
SK734-2000A SK7342000A3 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Country Status (24)

Country Link
EP (1) EP1033986A1 (fr)
JP (1) JP2001523718A (fr)
KR (1) KR20010032320A (fr)
CN (1) CN1279608A (fr)
AP (1) AP2000001821A0 (fr)
AR (1) AR015485A1 (fr)
AU (1) AU1168099A (fr)
BG (1) BG104527A (fr)
BR (1) BR9814220A (fr)
CO (1) CO4970832A1 (fr)
DZ (1) DZ2658A1 (fr)
EA (1) EA200000552A1 (fr)
GB (1) GB9724544D0 (fr)
HU (1) HUP0100580A3 (fr)
IL (1) IL136106A0 (fr)
MA (1) MA24704A1 (fr)
NO (1) NO20002590L (fr)
OA (1) OA11385A (fr)
PE (1) PE20000381A1 (fr)
PL (1) PL340555A1 (fr)
SK (1) SK7342000A3 (fr)
TR (1) TR200001423T2 (fr)
WO (1) WO1999026625A1 (fr)
ZA (1) ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
CA2367402C (fr) * 1999-03-12 2010-11-23 Basf Aktiengesellschaft Forme pharmaceutique stable pour anhydrate de paroxetine
DE60004768T2 (de) 1999-07-01 2004-07-08 Italfarmaco S.P.A. Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
WO2003055468A1 (fr) * 2001-12-21 2003-07-10 Shire Laboratories Inc. Formulation de gelule a administration orale presentant une stabilite physique accrue
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (fr) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S Composition pharmaceutique comprenant un antagoniste de l'aldosterone
EP2510924B1 (fr) * 2009-12-08 2014-10-08 IL Hwa Co., Ltd DISPERSIONS SOLIDES CONTENANT DU 20-O-ß-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031197A1 (fr) * 1995-04-03 1996-10-10 Abbott Laboratories Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
AU730532B2 (en) * 1997-01-15 2001-03-08 Smithkline Beecham Plc Paroxetine compositions

Also Published As

Publication number Publication date
NO20002590D0 (no) 2000-05-19
EA200000552A1 (ru) 2000-10-30
OA11385A (en) 2004-01-27
NO20002590L (no) 2000-07-19
IL136106A0 (en) 2001-05-20
WO1999026625A1 (fr) 1999-06-03
ZA9810637B (en) 2000-05-22
PE20000381A1 (es) 2000-05-07
GB9724544D0 (en) 1998-01-21
AU1168099A (en) 1999-06-15
PL340555A1 (en) 2001-02-12
MA24704A1 (fr) 1999-07-01
JP2001523718A (ja) 2001-11-27
CO4970832A1 (es) 2000-11-07
HUP0100580A2 (hu) 2002-04-29
DZ2658A1 (fr) 2003-03-22
EP1033986A1 (fr) 2000-09-13
AP2000001821A0 (en) 2000-06-30
CN1279608A (zh) 2001-01-10
AR015485A1 (es) 2001-05-02
TR200001423T2 (tr) 2000-10-23
BR9814220A (pt) 2001-12-26
BG104527A (en) 2001-04-30
KR20010032320A (ko) 2001-04-16
HUP0100580A3 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
US6524615B2 (en) Controlled release pharmaceutical composition
US6491950B1 (en) Controlled release pharmaceutical composition
US6372251B2 (en) Formulations comprising lipid-regulating agents
US8293270B2 (en) Lipophilic vehicle-based dual controlled release matrix system
CA2365128A1 (fr) Preparations contenant des agents regulateurs de lipides
SK7342000A3 (en) Formulations comprising dissolved paroxetine
US6838091B2 (en) Formulations comprising lipid-regulating agents
KR100679582B1 (ko) 경질 쉘 캡슐용 이부프로펜 용액
KR20040006887A (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
US6814977B1 (en) Formulations comprising lipid-regulating agents
WO2021163023A1 (fr) Formulations stables de dronabinol
US20020032220A1 (en) Formulations comprising dissolved paroxetine
US20040146537A1 (en) Oily wax matrix suspension formulation comprising pharmacologically active agents
US20020040046A1 (en) Novel formulations comprising lipid-regulating agents
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin
WO2000072829A1 (fr) Formulations comprenant des agents regulateurs des lipides
MXPA00005030A (en) Formulations comprising dissolved paroxetine
CA2310407A1 (fr) Formulations contenant de la paroxetine dissoute
SI8710407A (sl) Postopek za pridobivanje trdnega pripravka s podaljšanim sproščanjem aktivne spojine